Safety and immunogenicity of GSK Biologicals’ HPV-16/18 L1 VLP AS04 vaccine (GSK-580299) in healthy female children 4-6 years old. - Trial 2011-005604-15
Access comprehensive clinical trial information for 2011-005604-15 through Pure Global AI's free database. This phase not specified trial is sponsored by GlaxoSmithKline Biologicals and is currently status unknown. The study focuses on Healthy volunteers.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to EU Clinical Trials Register data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
2011-005604-15
Trial Details
EU Clinical Trials Register • 2011-005604-15
Safety and immunogenicity of GSK Biologicals’ HPV-16/18 L1 VLP AS04 vaccine (GSK-580299) in healthy female children 4-6 years old.
Study Focus
Sponsor & Location
GlaxoSmithKline Biologicals
Timeline & Enrollment
N/A
N/A
N/A
Primary Outcome
The occurrence and intensity of solicited local adverse events (AEs).
ICD-10 Classifications
Healthy person accompanying sick person
Routine general health check-up of armed forces
Routine general health check-up of sports teams
Routine general health check-up of inhabitants of institutions
Data Source
EU Clinical Trials Register
2011-005604-15
Non-Device Trial